Literature DB >> 17676048

An HSV vector system for selection of ligand-gated ion channel modulators.

Rahul Srinivasan1, Shaohua Huang, Suchita Chaudhry, Adrian Sculptoreanu, David Krisky, Michael Cascio, Peter A Friedman, William C de Groat, Darren Wolfe, Joseph C Glorioso.   

Abstract

Pathological alterations of ion channel activity result from changes in modulatory mechanisms governing receptor biology. Here we describe a conditional herpes simplex virus (HSV) replication-based strategy to discover channel modulators whereby inhibition of agonist-induced channel activation by a vector-expressed modulatory gene product prevents ion flux, osmotic shock and cell death. Inhibition of channel activity, in this case, the rat vanilloid (Trpv1 or the glycine receptor (GlyRalpha1), can allow selection of escape vector plaques containing the 'captured' modulatory gene for subsequent identification and functional analysis. We validated this prediction using mixed infections of a wild-type Trpv1 expression vector vTTHR and a nonfunctional 'poreless' Trpv1 subunit-expressing vector, vHP, wherein vHP was highly selected from a large background of vTTHR viruses in the presence of the Trpv1 agonist, capsaicin. The approach should be useful for probing large libraries of vector-expressed cDNAs for the presence of ion channel modulators.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17676048      PMCID: PMC3133941          DOI: 10.1038/nmeth1077

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


  24 in total

1.  Voltage- and time-dependent properties of the recombinant rat vanilloid receptor (rVR1).

Authors:  M J Gunthorpe; M H Harries; R K Prinjha; J B Davis; A Randall
Journal:  J Physiol       Date:  2000-06-15       Impact factor: 5.182

2.  Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture.

Authors:  X p Chen; J Li; M Mata; J Goss; D Wolfe; J C Glorioso; D J Fink
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Development of replication-defective herpes simplex virus vectors.

Authors:  William F Goins; David M Krisky; Darren P Wolfe; David J Fink; Joseph C Glorioso
Journal:  Methods Mol Med       Date:  2002

Review 4.  Ion channel diseases.

Authors:  Christian A Hübner; Thomas J Jentsch
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

5.  Identification of a tetramerization domain in the C terminus of the vanilloid receptor.

Authors:  Nuria García-Sanz; Asia Fernández-Carvajal; Cruz Morenilla-Palao; Rosa Planells-Cases; Emmanuel Fajardo-Sánchez; Gregorio Fernández-Ballester; Antonio Ferrer-Montiel
Journal:  J Neurosci       Date:  2004-06-09       Impact factor: 6.167

Review 6.  Investigating membrane protein dynamics in living cells.

Authors:  Ian R Bates; Paul W Wiseman; John W Hanrahan
Journal:  Biochem Cell Biol       Date:  2006-12       Impact factor: 3.626

Review 7.  Ondansetron: a selective 5-HT(3) receptor antagonist and its applications in CNS-related disorders.

Authors:  J H Ye; R Ponnudurai; R Schaefer
Journal:  CNS Drug Rev       Date:  2001

Review 8.  Carvedilol and vesnarinone: new antiarrhythmic approach in heart failure therapy.

Authors:  J H Cheng; K Kamiya; I Kodama
Journal:  Acta Pharmacol Sin       Date:  2001-03       Impact factor: 6.150

9.  Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist.

Authors:  M J Gunthorpe; H K Rami; J C Jerman; D Smart; C H Gill; E M Soffin; S Luis Hannan; S C Lappin; J Egerton; G D Smith; A Worby; L Howett; D Owen; S Nasir; C H Davies; M Thompson; P A Wyman; A D Randall; J B Davis
Journal:  Neuropharmacology       Date:  2004-01       Impact factor: 5.250

10.  N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties.

Authors:  Kenneth J Valenzano; Elfrida R Grant; Gang Wu; Mohamed Hachicha; Lori Schmid; Laykea Tafesse; Qun Sun; Yakov Rotshteyn; Joseph Francis; James Limberis; Shiazah Malik; Edward R Whittemore; Dianne Hodges
Journal:  J Pharmacol Exp Ther       Date:  2003-04-29       Impact factor: 4.030

View more
  11 in total

Review 1.  Gene therapy for the treatment of chronic peripheral nervous system pain.

Authors:  William F Goins; Justus B Cohen; Joseph C Glorioso
Journal:  Neurobiol Dis       Date:  2012-06-02       Impact factor: 5.996

Review 2.  Herpes simplex viral vectors: late bloomers with big potential.

Authors:  Joseph C Glorioso
Journal:  Hum Gene Ther       Date:  2014-02       Impact factor: 5.695

3.  A herpes simplex virus vector system for expression of complex cellular cDNA libraries.

Authors:  Darren Wolfe; April M Craft; Justus B Cohen; Joseph C Glorioso
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

4.  Herpes Simplex Virus Vector-Mediated Gene Delivery of Poreless TRPV1 Channels Reduces Bladder Overactivity and Nociception in Rats.

Authors:  Tsuyoshi Majima; Yasuhito Funahashi; Shun Takai; William F Goins; Momokazu Gotoh; Pradeep Tyagi; Joseph C Glorioso; Naoki Yoshimura
Journal:  Hum Gene Ther       Date:  2015-08-31       Impact factor: 5.695

Review 5.  HSV vector-mediated modification of primary nociceptor afferents: an approach to inhibit chronic pain.

Authors:  J R Goss; M S Gold; J C Glorioso
Journal:  Gene Ther       Date:  2009-04       Impact factor: 5.250

6.  Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception.

Authors:  Hitoshi Yokoyama; Tomohiko Oguchi; William F Goins; James R Goss; Osamu Nishizawa; William C de Groat; Darren Wolfe; David M Krisky; Joseph C Glorioso; Naoki Yoshimura
Journal:  Hum Gene Ther       Date:  2013-02-14       Impact factor: 5.695

Review 7.  Herpes vector-mediated gene transfer in the treatment of chronic pain.

Authors:  Joseph C Glorioso; David J Fink
Journal:  Mol Ther       Date:  2008-10-07       Impact factor: 11.454

8.  Protein kinase C epsilon contributes to basal and sensitizing responses of TRPV1 to capsaicin in rat dorsal root ganglion neurons.

Authors:  Rahul Srinivasan; Darren Wolfe; James Goss; Simon Watkins; William C de Groat; Adrian Sculptoreanu; Joseph C Glorioso
Journal:  Eur J Neurosci       Date:  2008-10       Impact factor: 3.386

9.  Relief of pain induced by varicella-zoster virus in a rat model of post-herpetic neuralgia using a herpes simplex virus vector expressing enkephalin.

Authors:  J-M G Guedon; M Zhang; J C Glorioso; W F Goins; P R Kinchington
Journal:  Gene Ther       Date:  2014-05-15       Impact factor: 5.250

10.  Recombinant adeno-associated virus serotype 6 (rAAV2/6)-mediated gene transfer to nociceptive neurons through different routes of delivery.

Authors:  Chris Towne; Marie Pertin; Ahmed T Beggah; Patrick Aebischer; Isabelle Decosterd
Journal:  Mol Pain       Date:  2009-09-08       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.